Latest market price
14.87
-1.08-6.77%
OverviewShort InterestFilings
AVBPQT12ArriVent BioPharma, Inc.·NASDAQ
14.87-6.77%

Latest SEC Filings

Form category
DescriptionFilingDocument
Oct 26, 20268-KCurrent report
Oct 19, 20268-KCurrent report
Oct 13, 20268-KCurrent report
Oct 13, 2026SC 13GBeneficial ownership statement (passive)
Oct 08, 2026SC 13D/ABeneficial ownership statement (active, amended)
Oct 06, 20268-KCurrent report
Aug 12, 20268-KCurrent report
Aug 12, 202610-QQuarterly report
Jul 27, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Jun 22, 20268-KCurrent report
Jun 22, 20264Statement of changes in beneficial ownership
Jun 22, 20264Statement of changes in beneficial ownership
Jun 22, 20264Statement of changes in beneficial ownership
Jun 22, 20264Statement of changes in beneficial ownership
May 11, 202610-QQuarterly report
May 11, 20268-KCurrent report
May 11, 2026424B5Prospectus
May 11, 20268-KCurrent report
May 06, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Apr 28, 2026DEFA14AAdditional proxy soliciting materials
Apr 28, 2026ARSAnnual report to shareholders
Apr 28, 2026DEF 14ADefinitive proxy statement
Mar 17, 20268-KCurrent report
Mar 05, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Mar 05, 20268-KCurrent report
#1 / 25 of 158
Page
▼
/ 7